Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01333423
Brief Title: Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)

First Submitted : April 8, 2011
First Submitted that Met QC Criteria : April 11, 2011
First Posted : April 12, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : June 22, 2012
Last Update Posted : June 26, 2012 (Estimate)